Old Web
English
Sign In
Acemap
>
authorDetail
>
Koji Yokomura
Koji Yokomura
Hamamatsu University
Medicine
Epidermal growth factor receptor
Phases of clinical research
Erlotinib
Lung cancer
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II Study Of Erlotinib As Third-Line Monotherapy In Patients With Advanced Non-Small-Cell Lung Cancer Without Epidermal Growth Factor Receptor Mutations
2012
ATS | American Thoracic Society International Conference
Shun Matsuura
Naoki Inui
Yuichi Ozawa
Toshihiro Shirai
Mikio Toyoshima
Takashi Yamada
Hideki Suganuma
Kazumasa Yasuda
Koji Yokomura
Takafumi Suda
Kingo Chida
Show All
Source
Cite
Save
Citations (0)
Phase II Study of Erlotinib as Third-line Monotherapy in Patients with Advanced Non-small-cell Lung Cancer without Epidermal Growth Factor Receptor Mutations
2011
Japanese Journal of Clinical Oncology
Shun Matsuura
Naoki Inui
Yuichi Ozawa
Yutaro Nakamura
Mikio Toyoshima
Kazumasa Yasuda
Takashi Yamada
Toshihiro Shirai
Hideki Suganuma
Koji Yokomura
Takafumi Suda
Kingo Chida
Show All
Source
Cite
Save
Citations (14)
1